Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 Red-Hot Growth Stocks That Are Still Cheap Buys


Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors. Three stocks that are doing well this year and that arguably still look cheap are Vertex Pharmaceuticals (NASDAQ: VRTX)Carnival (NYSE: CCL), and Alphabet (NASDAQ: GOOG). At less than 25 times their future earnings and plenty of growth potential, these high-flying stocks could just be getting warmed up.

It has been a strong year for Vertex Pharmaceuticals stock. Up around 25% year to date, it's trading near its 52-week high as the business has continued to do well this year with revenue rising 13% year to date and more growth still on the horizon.

But despite its gains to date, this healthcare stock could be heading even higher in the future. That's because the business is getting bigger and more diverse. Today its revenue predominantly comes from its cystic fibrosis (CF) drugs -- but that could soon change.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Aktie

470,00 €
0,44 %
Ein geringer Gewinn bei Vertex Pharmaceuticals Inc. heute, um 0,44 %.
Vertex Pharmaceuticals Inc. ist ein klarer Community-Favorit mit mehr Buy- als Sell-Einschätzungen.
Trotz eines Kursziels von 450 €, das unter 470.0 € liegt, ergibt sich für Vertex Pharmaceuticals Inc. ein negatives Potenzial von -4.26%.
Like: 0
Teilen

Kommentare